Birchview Capital, LP
- SEC CIK
- 0001618205
- Latest filing
- Aug 14, 2026
Holdings in Q4 2025
Holdings as of Dec 31, 2025, filed Feb 13, 2026. Long positions only; changes compare share counts with Q3 2025.
- Positions
- 68
- −1 vs. Q3 2025
- Portfolio value
- $170.8M
- +$38.4M (+29.0%) vs. Q3 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| KLACKLA Corp | COM NEW | 21,883 | $26.6M | 15.6% | 00.0% | Unchanged | History |
| BMYBristol Myers Squibb Co | Stock | 302,842 | $16.3M | 9.6% | −14,000−4.4% | Reduced | History |
| CMPXCompass Therapeutics, Inc. | COM | 1,592,938 | $8.55M | 5.0% | +720,000+82.5% | Added | History |
| STOKStoke Therapeutics, Inc. | COM | 260,000 | $8.25M | 4.8% | +50,000+23.8% | Added | History |
| LRCXLam Research Corp | Stock | 40,329 | $6.90M | 4.0% | +40,329 | New | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 269,000 | $6.72M | 3.9% | +95,000+54.6% | Added | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 90,000 | $6.26M | 3.7% | +12,000+15.4% | Added | History |
| PTGXProtagonist Therapeutics, Inc | COM | 55,000 | $4.80M | 2.8% | +7,000+14.6% | Added | History |
| ACADAcadia Pharmaceuticals Inc | COM | 171,000 | $4.57M | 2.7% | 00.0% | Unchanged | History |
| OVVOvintiv Inc. | COM | 107,500 | $4.21M | 2.5% | 00.0% | Unchanged | History |
| PRTAProthena Corp Public Ltd Co | SHS | 441,019 | $4.21M | 2.5% | −108,000−19.7% | Reduced | History |
| SLDBSolid Biosciences Inc. | COM NEW | 705,955 | $3.98M | 2.3% | +409,000+137.7% | Added | History |
| NBIXNeurocrine Biosciences Inc | Stock | 27,190 | $3.86M | 2.3% | −1,500−5.2% | Reduced | History |
| FOLDAmicus Therapeutics, Inc. | COM | 253,000 | $3.60M | 2.1% | 00.0% | Unchanged | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 462,700 | $3.28M | 1.9% | +308,700+200.5% | Added | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 195,000 | $3.24M | 1.9% | +110,000+129.4% | Added | History |
| CSTLCastle Biosciences Inc | COM | 80,600 | $3.14M | 1.8% | −30,000−27.1% | Reduced | History |
| NTLAIntellia Therapeutics, Inc. | COM | 315,400 | $2.84M | 1.7% | +255,400+425.7% | Added | History |
| IMNMImmunome Inc. | COM | 130,000 | $2.79M | 1.6% | +25,000+23.8% | Added | History |
| CORTCorcept Therapeutics Inc | COM | 67,200 | $2.34M | 1.4% | 00.0% | Unchanged | History |
| VERAVera Therapeutics, Inc. | CL A | 44,000 | $2.23M | 1.3% | +44,000 | New | History |
| QDELQuidelOrtho Corp | COM | 72,548 | $2.07M | 1.2% | 00.0% | Unchanged | History |
| NVCRNovoCure Ltd | ORD SHS | 152,100 | $1.97M | 1.2% | +50,000+49.0% | Added | History |
| BDSXBiodesix Inc | COM | 286,804 | $1.95M | 1.1% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 30,000 | $1.91M | 1.1% | 00.0% | Unchanged | History |
| PHRPhreesia, Inc. | COM | 110,700 | $1.87M | 1.1% | −4,000−3.5% | Reduced | History |
| EQTEQT Corp | Stock | 34,619 | $1.86M | 1.1% | 00.0% | Unchanged | History |
| HROWHarrow, Inc. | COM | 34,000 | $1.67M | 1.0% | −6,000−15.0% | Reduced | History |
| TVTXTravere Therapeutics, Inc. | COM | 43,000 | $1.64M | 1.0% | −60−0.1% | Reduced | History |
| FHTXFoghorn Therapeutics Inc. | COM | 281,730 | $1.52M | 0.9% | 00.0% | Unchanged | History |
| UTHRUnited Therapeutics Corp | COM | 3,000 | $1.46M | 0.9% | 00.0% | Unchanged | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 62,000 | $1.43M | 0.8% | +40,000+181.8% | Added | History |
| ALKSAlkermes plc. | SHS | 50,000 | $1.40M | 0.8% | 00.0% | Unchanged | History |
| NKTRNektar Therapeutics | COM NEW | 31,000 | $1.31M | 0.8% | +26,979+671.0% | Added | History |
| APGEApogee Therapeutics, Inc. | COM | 16,000 | $1.21M | 0.7% | 00.0% | Unchanged | History |
| VSTMVerastem, Inc. | COM NEW | 150,000 | $1.16M | 0.7% | +150,000 | New | History |
| AXSMAxsome Therapeutics, Inc. | COM | 6,061 | $1.11M | 0.6% | +61+1.0% | Added | History |
| MASIMasimo Corp | COM | 8,280 | $1.08M | 0.6% | 00.0% | Unchanged | History |
| TXG10x Genomics, Inc. | CL A COM | 59,000 | $962.3K | 0.6% | +59,000 | New | History |
| XENEXenon Pharmaceuticals Inc. | COM | 21,000 | $941.2K | 0.6% | 00.0% | Unchanged | History |
| PACBPacific Biosciences of California, Inc. | COM | 500,000 | $935.0K | 0.5% | 00.0% | Unchanged | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 57,000 | $920.5K | 0.5% | −10,000−14.9% | Reduced | History |
| FCXFreeport-McMoran Inc | Stock | 18,046 | $916.6K | 0.5% | +20.0% | Added | History |
| VTYXVentyx Biosciences, Inc. | COM | 100,827 | $910.5K | 0.5% | +2,000+2.0% | Added | History |
| PHVSPharvaris N.V. | COM | 29,847 | $828.3K | 0.5% | +15,000+101.0% | Added | History |
| ILMNIllumina, Inc. | COM | 6,000 | $787.0K | 0.5% | +6,000 | New | History |
| QUREuniQure N.V. | SHS | 30,789 | $736.8K | 0.4% | −47,939−60.9% | Reduced | History |
| HALOHalozyme Therapeutics, Inc. | COM | 10,100 | $679.7K | 0.4% | 00.0% | Unchanged | History |
| BHVNBiohaven Ltd. | COM | 59,365 | $670.2K | 0.4% | +59,365 | New | History |
| BBIOBridgeBio Pharma, Inc. | COM | 8,688 | $664.5K | 0.4% | 00.0% | Unchanged | History |
| TMCITreace Medical Concepts, Inc. | COM | 226,947 | $556.0K | 0.3% | +50,000+28.3% | Added | History |
| LUNGPulmonx Corp | COM | 250,573 | $553.8K | 0.3% | +250,573 | New | History |
| RAPTRAPT Therapeutics, Inc. | COM NEW | 15,000 | $508.1K | 0.3% | +15,000 | New | History |
| GOSSGossamer Bio, Inc. | COM | 138,176 | $428.3K | 0.3% | 00.0% | Unchanged | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 18,058 | $379.9K | 0.2% | −14,942−45.3% | Reduced | History |
| OMOutset Medical, Inc. | COM | 98,913 | $367.0K | 0.2% | +20,329+25.9% | Added | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 14,000 | $351.7K | 0.2% | 00.0% | Unchanged | History |
| LQDALiquidia Corp | COM NEW | 10,000 | $344.9K | 0.2% | +10,000 | New | History |
| CADLCandel Therapeutics, Inc. | COM | 60,000 | $339.0K | 0.2% | 00.0% | Unchanged | History |
| VYGRVoyager Therapeutics, Inc. | COM | 74,918 | $294.4K | 0.2% | −60,000−44.5% | Reduced | History |
| TRINTrinity Capital Inc. | COM | 20,000 | $293.0K | 0.2% | +20,000 | New | History |
| INBXInhibrx Biosciences, Inc. | COM | 3,698 | $292.1K | 0.2% | −28,000−88.3% | Reduced | History |
| KBDCKayne Anderson BDC, Inc. | COM SHS | 20,000 | $286.4K | 0.2% | +20,000 | New | History |
| CGEMCullinan Therapeutics, Inc. | COM | 20,000 | $207.0K | 0.1% | 00.0% | Unchanged | History |
| ELUTElutia Inc. | CL A COM | 263,018 | $182.2K | 0.1% | −448,157−63.0% | Reduced | History |
| ALMSAlumis Inc. | COM | 10,000 | $97.6K | 0.1% | 00.0% | Unchanged | History |
| DCGODocGo Inc. | COM | 49,908 | $43.8K | <0.1% | −714,154−93.5% | Reduced | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 17,000 | $22.9K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q3 2025 (12)
Positions held at the end of Q3 2025 that are gone from this filing.
| Security | Class | Shares in Q3 2025 | Value in Q3 2025 | % of portfolio in Q3 2025 | History |
|---|---|---|---|---|---|
| AXGNAxogen, Inc. | COM | 119,078 | $2.12M | 1.6% | History |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 30,000 | $1.16M | 0.9% | History |
| SRRKScholar Rock Holding Corp | COM | 26,000 | $968.2K | 0.7% | History |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 31,000 | $394.0K | 0.3% | History |
| GHGuardant Health, Inc. | COM | 6,000 | $374.9K | 0.3% | History |
| ZBIOZenas BioPharma, Inc. | COM | 16,500 | $366.3K | 0.3% | History |
| KIDSOrthopediatrics Corp | COM | 16,000 | $296.5K | 0.2% | History |
| TELATELA Bio, Inc. | COM | 155,000 | $230.9K | 0.2% | History |
| State Street Health Care Select Sector SPDR ETF81369Y209 | ETF | 1,498 | $208.5K | 0.2% | – |
| KPTIKaryopharm Therapeutics Inc. | COM | 27,985 | $183.0K | 0.1% | History |
| APLTApplied Therapeutics, Inc. | COM | 225,000 | $136.1K | 0.1% | History |
| IFRXInflaRx N.V. | COM | 50,000 | $67.0K | 0.1% | History |